Correlation Between Ventyx Biosciences and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ventyx Biosciences and Emergent Biosolutions, you can compare the effects of market volatilities on Ventyx Biosciences and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Emergent Biosolutions.
Diversification Opportunities for Ventyx Biosciences and Emergent Biosolutions
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Ventyx and Emergent is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Ventyx Biosciences and Emergent Biosolutions
Given the investment horizon of 90 days Ventyx Biosciences is expected to under-perform the Emergent Biosolutions. But the stock apears to be less risky and, when comparing its historical volatility, Ventyx Biosciences is 1.11 times less risky than Emergent Biosolutions. The stock trades about -0.02 of its potential returns per unit of risk. The Emergent Biosolutions is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 1,202 in Emergent Biosolutions on September 21, 2024 and sell it today you would lose (396.00) from holding Emergent Biosolutions or give up 32.95% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
Ventyx Biosciences vs. Emergent Biosolutions
Performance |
Timeline |
Ventyx Biosciences |
Emergent Biosolutions |
Ventyx Biosciences and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ventyx Biosciences and Emergent Biosolutions
The main advantage of trading using opposite Ventyx Biosciences and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.Ventyx Biosciences vs. Emergent Biosolutions | Ventyx Biosciences vs. Neurocrine Biosciences | Ventyx Biosciences vs. Teva Pharma Industries | Ventyx Biosciences vs. Haleon plc |
Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |